Coherus Oncology Inc
F:8C5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coherus Oncology Inc
F:8C5
|
US |
|
S
|
Southern Cross Media Group Ltd
SWB:6MM
|
AU |
|
C
|
China Oilfield Services Ltd
OTC:CHOLF
|
CN |
|
S
|
Southern Cross Media Group Ltd
F:6MM
|
AU |
|
E
|
Eastern Water Resources Development and Management PCL
SET:EASTW
|
TH |
|
Agora Inc
F:9AG1
|
US |
|
A
|
Agora Inc
DUS:9AG1
|
US |
|
R
|
Relx PLC
DUS:RDEB
|
UK |
|
C
|
Coherus Oncology Inc
SWB:8C5
|
US |
|
C
|
China Oilfield Services Ltd
F:CO9
|
CN |
|
C
|
Charter Communications Inc
F:CQD
|
US |
|
Standard BioTools Inc
NASDAQ:LAB
|
US |
|
C
|
China Oilfield Services Ltd
XMUN:CO9
|
CN |
Bankruptcy Probability
Coherus Oncology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Coherus Oncology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Coherus Oncology Inc
NASDAQ:CHRS
|
115.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
509.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
96.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
96.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
38.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Coherus Oncology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Coherus Oncology Inc has total debt of 51.8m USD. This includes both short-term (0 USD) and long-term (51.8m USD) debt.
You can find a full breakdown on its Balance Sheet.
